If you need more lookups,
subscriptions start at $34 USD/month.
Albert Kraus Location
Guilford, CT, US
Albert Kraus Work
2023 -now Entrepreneur in Residence @
2023 -now Managing Partner @ GDS Partners LLC
2023 -now Advisory Board Member @
2019 -2024 Industry Representative to the US FDA Oncologic Drugs Advisory Committee (ODAC) @
2011 -2023 Oncology Global Regulatory Strategy Portfolio Lead @
2009 -2011 Vice President: Medicine Development @ Onyx Pharmaceuticals (acquired Proteolix)(acquired by Amgen)
2008 -2009 Vice President: Regulatory Affairs and Quality Assurance @ Proteolix (acquired by Onyx Pharmaceutricals)
2006 -2008 Board Member @ Kosan Bioscience Europe LTD
2006 -2008 Vice President: Drug Development, Pharmacovigilance and Regulatory Affairs @
1997 -2006 Group Director: Global Regulatory Strategy and US FDA Liason @
1985 -1997 Section Head, Toxicology, Human Safety and Regulatory Affairs @
Albert Kraus Education
University of Michigan
PhD (Biochemical Toxicology/ Cellular Chemistry)
1981-1985
Hamilton College
AB (Biology, Economics)
1977-1981
Albert Kraus Summary
Albert Kraus, based in Guilford, CT, US, is currently a Entrepreneur in Residence at Yale University. Albert Kraus brings experience from previous roles at GDS Partners LLC, NDA Group AB, FDA and Pfizer. Albert Kraus holds a 1981 - 1985 PhD in Biochemical Toxicology/ Cellular Chemistry @ University of Michigan. Albert Kraus has 1 emails on RocketReach.
Looking for a different Albert Kraus?
Find contact details for 700 million professionals.